Terms: = Gastric cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
23 results:
1. Down-regulation of stimulator of interferon genes (STING) expression and CD8
Fukai S; Nakajima S; Saito M; Saito K; Kase K; Nakano H; Sato T; Sakuma M; Kaneta A; Okayama H; Mimura K; Sakamoto W; Saze Z; Momma T; Kono K
Gastric Cancer; 2023 Nov; 26(6):878-890. PubMed ID: 37542528
[TBL] [Abstract] [Full Text] [Related]
2. cGAS regulates the DNA damage response to maintain proliferative signaling in gastric cancer cells.
Liu B; Liu H; Ren F; Liu H; Bukhari I; Fu Y; Wu W; Zhao M; Zhu S; Mo H; Li F; Zheng MB; Tang Y; Zheng P; Mi Y
Oncol Res; 2021; 29(2):87-103. PubMed ID: 37305397
[TBL] [Abstract] [Full Text] [Related]
3. IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer.
Lutz MS; Zekri L; Weßling L; Berchtold S; Heitmann JS; Lauer UM; Jung G; Salih HR
Front Immunol; 2023; 14():1163136. PubMed ID: 37122707
[TBL] [Abstract] [Full Text] [Related]
4. Expression of SASP, DNA Damage Response, and Cell Proliferation Factors in Early gastric Neoplastic Lesions: Correlations and Clinical Significance.
Liang L; Chai Y; Chai F; Liu H; Ma N; Zhang H; Zhang S; Nong L; Li T; Zhang B
Pathol Oncol Res; 2022; 28():1610401. PubMed ID: 36061145
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Perspectives of STING and PD-L1 Expression and Correlation with the Prognosis of Epstein-Barr Virus-Associated gastric cancers.
Sun Q; Fu Y; Chen X; Li L; Wu H; Liu Y; Xu H; Zhou G; Fan X; Xia H
Gut Liver; 2022 Nov; 16(6):875-891. PubMed ID: 35611665
[TBL] [Abstract] [Full Text] [Related]
6. Combinatorial targeting of Hippo-STRIPAK and PARP elicits synthetic lethality in gastrointestinal cancers.
An L; Cao Z; Nie P; Zhang H; Tong Z; Chen F; Tang Y; Han Y; Wang W; Zhao Z; Zhao Q; Yang Y; Xu Y; Fang G; Shi L; Xu H; Ma H; Jiao S; Zhou Z
J Clin Invest; 2022 May; 132(9):. PubMed ID: 35290241
[TBL] [Abstract] [Full Text] [Related]
7. cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers.
Ke X; Hu T; Jiang M
FASEB J; 2022 Jan; 36(1):e22029. PubMed ID: 34907606
[TBL] [Abstract] [Full Text] [Related]
8. Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers.
Weinberg DS; Foster NR; Della'Zanna G; McMurray RP; Kraft WK; Pallotto A; Kastenberg DM; Katz LC; Henry CH; Moleski SM; Limburg PJ; Waldman SA
Cancer Biol Ther; 2021 Dec; 22(10-12):544-553. PubMed ID: 34632925
[TBL] [Abstract] [Full Text] [Related]
9. Identification and validation of the prognostic value of cyclic gmp-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract] [Full Text] [Related]
10. Extracellular matrix hydrogel derived from decellularized tissues enables endodermal organoid culture.
Giobbe GG; Crowley C; Luni C; Campinoti S; Khedr M; Kretzschmar K; De Santis MM; Zambaiti E; Michielin F; Meran L; Hu Q; van Son G; Urbani L; Manfredi A; Giomo M; Eaton S; Cacchiarelli D; Li VSW; Clevers H; Bonfanti P; Elvassore N; De Coppi P
Nat Commun; 2019 Dec; 10(1):5658. PubMed ID: 31827102
[TBL] [Abstract] [Full Text] [Related]
11. The ERBB2 gene polymorphisms rs2643194, rs2934971, and rs1058808 are associated with increased risk of gastric cancer.
Vázquez-Ibarra KC; Bustos-Carpinteyro AR; García-Ruvalcaba A; Magaãa-Torres MT; Gutiérrez-Aguilar R; Marín-Contreras ME; Santiago-Luna E; Sánchez-López JY
Braz J Med Biol Res; 2019; 52(5):e8379. PubMed ID: 31116314
[TBL] [Abstract] [Full Text] [Related]
12. Bioactivity of Oral Linaclotide in Human Colorectum for cancer Chemoprevention.
Weinberg DS; Lin JE; Foster NR; Della'Zanna G; Umar A; Seisler D; Kraft WK; Kastenberg DM; Katz LC; Limburg PJ; Waldman SA
Cancer Prev Res (Phila); 2017 Jun; 10(6):345-354. PubMed ID: 28396341
[TBL] [Abstract] [Full Text] [Related]
13. Association between the CDH1-472delA and -160C>A polymorphisms and diffuse and intestinal gastric cancer in a Mexican population.
Bustos-Carpinteyro AR; Delgado-Figueroa N; Santiago-Luna E; Magaña-Torres MT; Sánchez-López JY
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706737
[TBL] [Abstract] [Full Text] [Related]
14. Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging.
Goldstein R; Sosabowski J; Livanos M; Leyton J; Vigor K; Bhavsar G; Nagy-Davidescu G; Rashid M; Miranda E; Yeung J; Tolner B; Plückthun A; Mather S; Meyer T; Chester K
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):288-301. PubMed ID: 25391547
[TBL] [Abstract] [Full Text] [Related]
15. Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity.
Voskens CJ; Watanabe R; Rollins S; Campana D; Hasumi K; Mann DL
J Exp Clin Cancer Res; 2010 Oct; 29(1):134. PubMed ID: 20937115
[TBL] [Abstract] [Full Text] [Related]
16. Diverse proteomic alterations in gastric adenocarcinoma.
He QY; Cheung YH; Leung SY; Yuen ST; Chu KM; Chiu JF
Proteomics; 2004 Oct; 4(10):3276-87. PubMed ID: 15378696
[TBL] [Abstract] [Full Text] [Related]
17. Usefulness of immunomodulators for maturation of dendritic cells.
Ogihara T; Iinuma H; Okinaga K
Int J Oncol; 2004 Aug; 25(2):453-9. PubMed ID: 15254744
[TBL] [Abstract] [Full Text] [Related]
18. beta-Catenin signaling: therapeutic strategies in oncology.
Li H; Pamukcu R; Thompson WJ
Cancer Biol Ther; 2002; 1(6):621-5. PubMed ID: 12642683
[TBL] [Abstract] [Full Text] [Related]
19. Formation of 2-chloroinosine from guanosine by treatment of HNO(2) in the presence of NaCl.
Suzuki T; Ide H; Yamada M; Morii T; Makino K
Bioorg Med Chem; 2001 Nov; 9(11):2937-41. PubMed ID: 11597475
[TBL] [Abstract] [Full Text] [Related]
20. [Effect of 5-FU on the utilization of purine and pyrimidine by human gastric cancer cells (KATO III)].
Usami M; Wang J; Yasuda I; Saitoh Y; Yumisashi T; Abe K
Gan To Kagaku Ryoho; 1995 May; 22(6):747-51. PubMed ID: 7755382
[TBL] [Abstract] [Full Text] [Related]
[Next]